Financials NEXGEL, Inc.

Equities

NXGL

US65344E1073

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.21 USD -3.28% Intraday chart for NEXGEL, Inc. +1.84% +3.76%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 14.52 6.965 12.18 13.76 - -
Enterprise Value (EV) 1 14.52 6.965 12.18 13.76 13.76 13.76
P/E ratio -1.8 x -1.47 x -3.8 x -3.3 x -27.6 x 3.62 x
Yield - - - - - -
Capitalization / Revenue 9.36 x 3.4 x 2.98 x 2.23 x 1.48 x 0.96 x
EV / Revenue 9.36 x 3.4 x 2.98 x 2.23 x 1.48 x 0.96 x
EV / EBITDA - - - - - -
EV / FCF -5,328,240 x - - - - -
FCF Yield -0% - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 5,565 5,572 5,718 6,228 - -
Reference price 2 2.610 1.250 2.130 2.210 2.210 2.210
Announcement Date 3/21/22 3/28/23 4/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 1.551 2.048 4.089 6.17 9.323 14.28
EBITDA - - - - - - -
EBIT 1 - -2.57 -3.348 -3.477 -4.129 -0.499 3.885
Operating Margin - -165.7% -163.48% -85.03% -66.92% -5.35% 27.2%
Earnings before Tax (EBT) 1 - -4.31 -4.746 -3.188 -4.129 -0.499 3.885
Net income 1 -2.264 -4.31 -4.746 -3.157 -4.129 -0.499 3.885
Net margin - -277.89% -231.74% -77.21% -66.92% -5.35% 27.2%
EPS 2 -0.0300 -1.450 -0.8500 -0.5600 -0.6700 -0.0800 0.6100
Free Cash Flow - -2.726 - - - - -
FCF margin - -175.76% - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/31/21 3/21/22 3/28/23 4/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.533 0.396 0.561 0.568 0.524 0.62 1.167 1.221 1.082 1.207 1.405 1.691 1.867
EBITDA - - - - - - - - - - - - -
EBIT 1 -0.887 -0.812 -0.718 -1.037 -0.781 -0.883 -0.762 -0.612 -1.219 -1.06 -1.042 -1.023 -1.003
Operating Margin -166.42% -205.05% -127.99% -182.57% -149.05% -142.42% -65.3% -50.12% -112.66% -87.82% -74.16% -60.5% -53.72%
Earnings before Tax (EBT) 1 -1.639 -1.836 -1.035 -1.227 -0.648 -0.807 -0.642 -0.552 -1.187 -1.06 -1.042 -1.023 -1.003
Net income 1 -1.639 -1.836 -1.035 -1.227 -0.648 -0.814 -0.695 -0.552 -1.098 -1.06 -1.042 -1.023 -1.003
Net margin -307.5% -463.64% -184.49% -216.02% -123.66% -131.29% -59.55% -45.21% -101.48% -87.82% -74.16% -60.5% -53.72%
EPS 2 -1.420 -0.3300 -0.1900 -0.2200 -0.1100 -0.1500 -0.1200 -0.1000 -0.2000 -0.1800 -0.1700 -0.1600 -0.1600
Dividend per Share - - - - - - - - - - - - -
Announcement Date 3/21/22 5/13/22 8/10/22 11/8/22 3/28/23 5/15/23 8/14/23 11/13/23 4/1/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - -2.73 - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - 0.27 - - - - -
Capex / Sales - 17.34% - - - - -
Announcement Date 3/31/21 3/21/22 3/28/23 4/1/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.21 USD
Average target price
6 USD
Spread / Average Target
+171.49%
Consensus
  1. Stock Market
  2. Equities
  3. NXGL Stock
  4. Financials NEXGEL, Inc.